Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety

Authors :: Jesper Grønlund Holm
Astrid-Helene Ravn Jørgensen
Simon Francis Thomsen
Source :: Clinical Case Reports, Jorgensen, A-H R, Holm, J G & Thomsen, S F 2020, ' Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease : Report and systematic literature review of effectiveness and safety ', Clinical Case Reports, vol. 8, no. 12, pp. 2874-2877 . https://doi.org/10.1002/ccr3.3090, Clinical Case Reports, Vol 8, Iss 12, Pp 2873-2876 (2020)
Publication Year :: 2020
Publisher :: John Wiley and Sons Inc., 2020.
Abstract: Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

Full Text Access

Tools